Hung Yu-Chiang, Wang Pei-Wen, Pan Tai-Long, Bazylak Grzegorz, Leu Yann-Lii
Graduate Institute of Clinical Medical Sciences, Kaohsiung Division, Chang Gung University, Kaohsiung, Taiwan.
J Ethnopharmacol. 2009 Jul 30;124(3):463-74. doi: 10.1016/j.jep.2009.05.020. Epub 2009 May 27.
Still little is known about the cellular mechanisms that contribute to the attenuated proliferation of aortic smooth muscle cells under the influence of the oxidative stress factors such as homocysteine (Hcy). Thus, we aimed to evaluate whether Salvia miltiorrhiza Bunge (Labiatae), a Chinese medicinal herb widely used in folk medicine for therapy of variety of human cardiovascular disorders would modulate this Hcy promoted growth effect in model animal aortic cells system.
The Salvia miltiorrhiza roots aqueous extract (SMAE) containing 3,4-dihydroxybenzoic acid, 3,4-dihydroxyphenyl lactic acid and salvianolic acid B, as confirmed by narrow-bore HPLC analyses with binary gradient elution was used in variable concentrations for the treatment of the rat aortic smooth muscle A10 cells under Hcy stimulation. Two-dimensional electrophoresis (2-DE) coupled with MALDI-TOF mass spectrometry was applied for the elucidation of protein changes characterizing the response of the rat A10 cells into the Hcy-induced oxidative stress.
This study showed that a low dose (0.015 mg/mL) of the SMAE significantly inhibited growth (>60%, p<0.05) of the Hcy stimulated rat A10 cells. In addition, concentration of intracellular reactive oxygen species (ROS) obviously decreased in the rat A10 cells after its incubation with SMAE in terms of catalase increasing activity. Next, marked down-regulation of protein kinase C beta-1 (PKC beta-1) and phosphorylated mitogen-activated protein kinase (p-MAPK) expression suggest that observed inhibitory effect of the polyphenol-rich SMAE on the Hcy-induced growth of rat A10 cells was realized via the PKC/p44/42 MAPK-dependent pathway. The intensity changes of 10 protein spots in response of the rat A10 cells to the Hcy-induced oxidative damage as alpha-4-tropomyosin, vimentin, F1F0-ATP synthase (beta subunit), glucose regulated protein 75 (GRP75), actin (fragment), prohibitin, capping protein, plakoglobin, endoplasmic reticulum protein (ERp29), and peptidylprolyl isomerase A (PPIase A), were detected with statistical significance (p<0.05). Meanwhile, it was showed that used here SMAE resist carbonylation of specific cytoskeleton and chaperone proteins as vimentin, alpha-4-tropomyosin and GRP75, respectively, leading to phenotype transformations in the rat A10 cells.
These data suggest that applied here SMAE exerts its protective effect through circulating ROS suppression and subsequent modulation of protein carbonylation in rat aortic smooth muscle A10 cells. Redox-proteomics protocol highlighted in this study may be applicable in facilitating the assessing potential novel molecular therapeutic targets to reduce cardiovascular risk related with elevated Hcy levels in various human populations and elucidating new mechanisms through which protein functions can be regulated by the redox status with the use of naturally occurring antioxidants.
关于同型半胱氨酸(Hcy)等氧化应激因素影响下主动脉平滑肌细胞增殖减弱的细胞机制,目前仍知之甚少。因此,我们旨在评估丹参(唇形科)这种在民间医学中广泛用于治疗多种人类心血管疾病的中药材,是否会在模型动物主动脉细胞系统中调节这种Hcy促进生长的效应。
通过二元梯度洗脱的窄孔高效液相色谱分析确认,含有3,4 - 二羟基苯甲酸、3,4 - 二羟基苯基乳酸和丹酚酸B的丹参根水提取物(SMAE),以不同浓度用于在Hcy刺激下处理大鼠主动脉平滑肌A10细胞。二维电泳(2 - DE)结合基质辅助激光解吸电离飞行时间质谱(MALDI - TOF)用于阐明表征大鼠A10细胞对Hcy诱导的氧化应激反应的蛋白质变化。
本研究表明,低剂量(0.015 mg/mL)的SMAE显著抑制Hcy刺激的大鼠A10细胞生长(>60%,p<0.05)。此外,就过氧化氢酶活性增加而言,大鼠A10细胞与SMAE孵育后细胞内活性氧(ROS)浓度明显降低。接下来,蛋白激酶Cβ - 1(PKCβ - 1)和磷酸化丝裂原活化蛋白激酶(p - MAPK)表达的显著下调表明,富含多酚的SMAE对Hcy诱导的大鼠A10细胞生长的观察到的抑制作用是通过PKC/p44/42 MAPK依赖性途径实现的。检测到大鼠A10细胞对Hcy诱导的氧化损伤反应中10个蛋白质斑点的强度变化具有统计学意义(p<0.05),这些蛋白质为α - 4 - 原肌球蛋白、波形蛋白、F1F0 - ATP合酶(β亚基)、葡萄糖调节蛋白75(GRP75)、肌动蛋白(片段)、抑制素、封端蛋白、桥粒斑蛋白、内质网蛋白(ERp29)和肽基脯氨酰异构酶A(PPIase A)。同时,结果表明这里使用的SMAE分别抵抗波形蛋白、α - 4 - 原肌球蛋白和GRP75等特定细胞骨架和伴侣蛋白的羰基化,导致大鼠A10细胞发生表型转变。
这些数据表明,这里应用的SMAE通过抑制循环ROS以及随后调节大鼠主动脉平滑肌A10细胞中的蛋白质羰基化发挥其保护作用。本研究中突出的氧化还原蛋白质组学方案可能适用于促进评估潜在的新型分子治疗靶点,以降低与不同人群中Hcy水平升高相关的心血管风险,并阐明蛋白质功能可通过使用天然抗氧化剂的氧化还原状态进行调节的新机制。